In STREAM stage 2, this study compared two bedaquiline-containing regimens with the 9-month STREAM stage 1 regimen. Both bedaquiline-containing regimens, a 9-month oral regimen and a 6-month regimen with 8 weeks of second-line injectable, had superior efficacy compared with a 9-month injectable-containing regimen, with fewer cases of hearing loss.
Published: November 8, 2022
Sign up to receive our monthly Research Roundup email, which offers a selection of new public health research from major journals.
Recent Abstracts
Monitoramento de Estratégias pelo Fim da Violência contra Crianças e Adolescentes
The Power of Storytelling: Guidance for the Creation of Testimonials
Lead Poisoning and Early Childhood Development
Prioritizing Evidence Gaps: Air Pollution and Health Impacts of Climate Action
Raising Alcohol Taxes to Reduce Harm: Fact Sheets for Brazil
Risk of mortality by aggression: A retrospective cohort study in women with notification…
How the Alcohol Industry Steers Governments Away From Effective Strategies to Curb Drink…
Analysis of the Efficacy of Alcohol Industry-Sponsored Drink-Driving Campaigns
Messaging Recommendations for Effective Road Safety Campaigns: Lessons From Formative Research for Drink…
Prescribing Psychostimulants for the Treatment of Stimulant Use Disorder: Navigating the Federal Legal…